Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review.

PLoS One · 2023 · PMC9815638 · PMID 36602979

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extraordinarily significantno p-value reported

Thus, treatment with a longer PFS is extraordinarily significant.

also in 60 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.